+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DNA and RNA Sample Preparation - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139533
The global market for DNA and RNA Sample Preparation was estimated at US$2.4 Billion in 2024 and is projected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the DNA and RNA Sample Preparation market.

Global DNA and RNA Sample Preparation Market - Key Trends and Drivers Summarized

What Is DNA and RNA Sample Preparation and Why Is It Critical?

DNA and RNA sample preparation is a fundamental process in molecular biology and genetics, involving the extraction, purification, and isolation of nucleic acids from biological samples. This process is critical because the quality and integrity of DNA and RNA are essential for downstream applications such as sequencing, PCR (Polymerase Chain Reaction), and gene expression analysis. The preparation of these samples requires meticulous steps to ensure that the nucleic acids are free from contaminants such as proteins, lipids, and other cellular debris that could interfere with analytical techniques. The importance of DNA and RNA sample preparation extends across various fields, including medical diagnostics, forensic science, and research, where accurate and reliable results depend on the purity and concentration of the nucleic acids obtained.

Technological Advances in DNA and RNA Sample Preparation: Improving Efficiency and Accuracy

In recent years, significant technological advancements have transformed the landscape of DNA and RNA sample preparation, making the process faster, more reliable, and less labor-intensive. Automation has played a pivotal role, with the development of automated extraction systems that streamline the process, reducing the risk of human error and contamination. These systems are capable of processing multiple samples simultaneously, improving throughput and consistency. Additionally, advancements in reagent chemistry have led to the creation of kits that allow for more efficient lysis of cells, enhanced binding of nucleic acids to purification matrices, and better elution techniques. These innovations have not only improved the yield and quality of DNA and RNA but have also expanded the range of sample types that can be processed, from blood and tissue to more challenging samples like formalin-fixed paraffin-embedded (FFPE) tissues and viral RNA.

Applications and Importance of DNA and RNA Sample Preparation in Various Fields

The applications of DNA and RNA sample preparation are vast and impact a wide range of scientific and clinical fields. In medical diagnostics, the ability to quickly and accurately prepare nucleic acids from patient samples is crucial for the detection of genetic mutations, infectious diseases, and cancer markers. Forensic science relies heavily on DNA sample preparation to analyze evidence from crime scenes, where even trace amounts of DNA can be critical in solving cases. In research, particularly in genomics and transcriptomics, the preparation of high-quality DNA and RNA samples is the foundation for experiments that seek to understand genetic functions and interactions. Moreover, the growing field of personalized medicine, which tailors treatments based on an individual’s genetic profile, depends on precise DNA and RNA sample preparation to ensure that the data generated is both accurate and actionable.

What Drives the Growth in the DNA and RNA Sample Preparation Market?

The growth in the DNA and RNA sample preparation market is driven by several factors, including the increasing demand for personalized medicine, the rising prevalence of genetic disorders, and the expanding use of molecular diagnostics. Technological advancements in extraction and purification methods are also playing a significant role, as they enhance the efficiency and accuracy of sample preparation processes, making them more accessible to a broader range of laboratories. The growing emphasis on research in genomics and proteomics, driven by initiatives such as the Human Genome Project, continues to fuel demand for high-quality nucleic acid samples. Additionally, the surge in infectious disease testing, particularly highlighted by the COVID-19 pandemic, has underscored the importance of reliable RNA sample preparation methods, further boosting the market. The integration of automation and the development of innovative kits that cater to a wide variety of sample types are also contributing to the rapid expansion of this market, ensuring its continued growth in both research and clinical settings.

SCOPE OF STUDY:

The report analyzes the DNA and RNA Sample Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Product (Kits, Workstations, Reagents & Consumables); Application (Research, Diagnostic Testing, Clinical Testing); End-Use (Diagnostic Centers, Hospitals, Contract Research Organizations, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Kits segment, which is expected to reach US$1.9 Billion by 2030 with a CAGR of a 4.5%. The Workstations segment is also set to grow at 5.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $656.6 Million in 2024, and China, forecasted to grow at an impressive 4.3% CAGR to reach $496.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global DNA and RNA Sample Preparation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global DNA and RNA Sample Preparation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global DNA and RNA Sample Preparation Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agilent Technologies, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories, Inc., DiaSorin SpA, F. Hoffmann-La Roche AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 11 companies featured in this DNA and RNA Sample Preparation market report include:

  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MilliporeSigma
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • DNA and RNA Sample Preparation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Expansion of Next-Generation Sequencing (NGS) Applications Strengthens Business Case for DNA and RNA Sample Preparation
  • Rising Adoption of DNA and RNA Sample Preparation in Clinical Diagnostics Spurs Market Growth
  • Growing Use of DNA and RNA Sample Preparation in Cancer Research Expands Market Opportunities
  • Increasing Investments in Biotechnology and Pharmaceutical R&D Propel Market for DNA and RNA Sample Preparation
  • Growing Applications of DNA and RNA Sample Preparation in Infectious Disease Research Drive Market Demand
  • Increasing Use of DNA and RNA Sample Preparation in Forensic Science Expands Addressable Market
  • Growing Adoption of DNA and RNA Sample Preparation in Liquid Biopsy Applications Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for DNA and RNA Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for DNA and RNA Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for DNA and RNA Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 15: World 15-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 17: World Historic Review for Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 18: World 15-Year Perspective for Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 20: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 21: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 26: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 27: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 31: World DNA and RNA Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 32: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 33: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 34: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
REST OF EUROPE
ASIA-PACIFIC
  • DNA and RNA Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MilliporeSigma
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

Table Information